MARKET

BIOL

BIOL

Biolase Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.755
-0.035
-0.73%
Opening 13:30 05/26 EDT
OPEN
4.740
PREV CLOSE
4.790
HIGH
4.950
LOW
4.712
VOLUME
18.27K
TURNOVER
56.99K
52 WEEK HIGH
23.49
52 WEEK LOW
3.300
MARKET CAP
29.36M
P/E (TTM)
-2.0424
1D
5D
1M
3M
1Y
5Y
BIOLASE CEO SHARES VISION FOR KINDLER, GENTLER DENTISTRY WITH CUSTOMERS AROUND THE WORLD
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, shared today that CEO John Beaver will continue his global "CEO on the Go" customer visit initiative throughout the year.
PR Newswire · 2d ago
58 Biggest Movers From Yesterday
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Benzinga · 2d ago
BIOLASE TO PARTICIPATE IN THE SPRING INTO ACTION BEST IDEAS VIRTUAL INVESTOR CONFERENCE MAY 17-20, 2022
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Spring Into Action Best Ideas Virtual Investor Conference being held May 17-20, 2022. John Beaver, President and Chief Executive Of...
PR Newswire · 05/16 20:05
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th \- 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global ...
ACCESSWIRE · 05/16 17:20
Biolase regains compliance with Nasdaq minimum bid price requirement
Biolase (NASDAQ:BIOL) received notice from the Nasdaq Stock on May 13 that it has regained compliance with the minimum bid price requirement for continued listing. The company is now in
Seekingalpha · 05/16 10:47
BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC (Nasdaq) on May 13, 2022 informing BIOLASE that it has regained
Benzinga · 05/16 10:32
BIOLASE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has received notice from the Nasdaq Stock Market LLC (Nasdaq) on May 13, 2022 informing BIOLASE that it has regained compliance with the minimum bid price requirement...
PR Newswire · 05/16 10:30
Biolase Q1 EPS $(0.77) Misses $(0.68) Estimate, Adj. EBITDA Loss $0.64/Share, Sales $10.20M Beat $9.01M Estimate
Biolase (NASDAQ:BIOL) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $(0.68) by 13.24 percent. This is a 39.84 percent increase over losses of $(1.28) per share from the
Benzinga · 05/12 20:25
More
No Data
Learn about the latest financial forecast of BIOL. Analyze the recent business situations of Biolase Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BIOL stock price target is 30.50 with a high estimate of 75.00 and a low estimate of 10.00.
High75.00
Average30.50
Low10.00
Current 4.755
EPS
Actual
Estimate
-0.86-0.65-0.43-0.22
    0
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 57
Institutional Holdings: 938.15K
% Owned: 15.20%
Shares Outstanding: 6.17M
TypeInstitutionsShares
Increased
6
5.64K
New
1
548
Decreased
1
211
Sold Out
6
2.30K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.96%
Healthcare Equipment & Supplies
+0.78%
Key Executives
Non-Executive Chairman/Independent Director
Jonathan Lord
President/Chief Executive Officer/Director
John Beaver
Director
Kathleen O'Loughlin
Director
Martha Somerman
Director
Carol Summerhays
Independent Director
Michael DiTolla
Independent Director
Richard Lanman
Independent Director
Jess Roper
Independent Director
Garrett Sato
Independent Director
Elaine Wagner
No Data
No Data
About BIOL
BIOLASE, Inc. (BIOLASE) provides laser systems for the dental industry. The Company develops, manufactures, markets and sells laser systems for dental practitioners and their patients. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. Waterlase dental laser systems flagship consist of the Waterlase Express, Waterlase iPlus, and the Waterlase MD and MDX which, produces electromagnetic energy with specific absorption and tissue interaction characteristics specifically designed for dental procedures in cutting hard tissue, such as bone and teeth, and soft tissue, such as gums and skin, without the heat, vibration, bleeding, or pressure associated with traditional dental treatments. Its diode soft tissue laser systems consist of the Epic X, Epic Hygiene, Epic Pro, Epic 10 and iLase diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief.

Webull offers kinds of BIOLASE Inc stock information, including NASDAQ:BIOL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIOL stock methods without spending real money on the virtual paper trading platform.